Skip to main content
logo
ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada flag Canada · Delayed Price · Currency is CAD
0.4950
+0.0450 (10.00%)
At close: May 6, 2026

ZYUS Life Sciences Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.370.410.480.350.30.21
Revenue Growth
-22.57%-15.80%37.04%17.79%43.96%-
Gross Profit
-0.06-0.01-0.96-2.01-0.640.14
Operating Income
-11.37-14.25-15.79-19.37-16.7-22.77
Net Income
-19.46-21.73-33.81-42.59-24.66-23.46
Earnings Per Share
-0.25-0.28-0.47-0.76-0.64-0.46
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.20.231.95.850.210.75
Total Debt
23.8415.9412.169.8134.925.64
Net Cash (Debt)
-23.64-15.7-10.26-3.95-34.69-24.89
Net Cash Growth
------
Net Cash Per Share
-0.30-0.20-0.14-0.07-0.90-0.49

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.1-9.23-9.88-17.95-9.57-16.86
Capital Expenditures
-0.01-0.01-0.05-0.28-0.56-4.99
Free Cash Flow
-7.11-9.24-9.92-18.23-10.13-21.85
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-15.51%-3.21%-199.38%--214.09%69.08%
Operating Margin
-3039.84%-3519.01%-3282.33%-5519.37%-5604.36%-10999.52%
Pretax Margin
-5202.41%-5365.68%-7462.16%-13800.28%-8293.62%-11387.44%
Profit Margin
-5202.41%-5365.68%-7028.07%-12134.19%-8274.16%-11330.92%
FCF Margin
-1900.27%-2281.73%-2062.79%-5193.45%-3400.67%-10553.14%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
106.57138.40145.32179.10--